Prognosis in women with interval breast cancer: population based observational cohort study

被引:32
作者
Kalager, Mette [1 ,2 ,3 ]
Tamimi, Rulla M. [1 ,4 ]
Bretthauer, Michael [2 ,5 ]
Adami, Hans-Olov [1 ,6 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway
[3] Telemark Hosp, Dept Clin Res, Skien, Norway
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA
[5] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat, N-0027 Oslo, Norway
[6] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
来源
BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 345卷
关键词
SCREENING-PROGRAM; TRUE INTERVAL; SURVIVAL; MAMMOGRAPHY; COMPLETENESS; FEATURES; REGISTRY; 10-YEAR; NORWAY; TIME;
D O I
10.1136/bmj.e7536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To compare the prognosis in women with interval breast cancer (cancer detected after a normal screening mammogram and before the next scheduled mammogram) with breast cancer detected among women not yet invited to mammography screening (non-screened). Design Population based observational study. Setting Norwegian breast cancer screening programme, implemented in different counties from 1996 to 2005. Participants 7116 women with a diagnosis of breast cancer at age 50 to 72 years; 1816 had interval breast cancer and 5300 had a diagnosis of breast cancer but had not yet been invited to screening. Main outcome measures Characteristics of the breast tumours, and survival of the women using Kaplan Meier curves and multivariable Cox proportional hazard models. Results Although interval cancers on average were slightly larger than the cancers in women not invited to screening, the histological type or status of axilliary lymph nodes did not differ noticeably between the two groups. Among interval cancers, there were no appreciable trends in size, nodal status, grade, or hormone receptor positivity associated with time since the last normal mammogram as a marker of growth rate. After 10 years of follow-up, the survival rates were 79.1% (95% confidence interval 75.4% to 82.3%) among women with interval cancers and 76.8% (75.3% to 78.2%) among women in the non-screened cancer group (hazard ratio 0.98, 95% confidence interval 0.84 to 1.15; P=0.53). Analyses stratified by time since last normal mammogram, age at diagnosis, or screening round showed similar results. Conclusion The prognosis of women with interval breast cancers was the same as that of women with breast cancers diagnosed without mammography screening.
引用
收藏
页数:10
相关论文
共 35 条
  • [1] MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL
    ANDERSSON, I
    ASPERGREN, K
    JANZON, L
    LANDBERG, T
    LINDHOLM, K
    LINELL, F
    LJUNGBERG, O
    RANSTAM, J
    SIGFUSSON, B
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6654) : 943 - 948
  • [2] Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden
    Bordas, P.
    Jonsson, H.
    Nystroem, L.
    Lenner, P.
    [J]. BREAST, 2007, 16 (01) : 47 - 54
  • [3] SURVIVAL IN INTERVAL BREAST-CANCER IN THE DOM SCREENING-PROGRAM
    BREKELMANS, CT
    PEETERS, PH
    DEURENBERG, JJ
    COLLETTE, HJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) : 1830 - 1835
  • [4] A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors
    Collett, K
    Stefansson, IM
    Eide, J
    Braaten, A
    Wang, H
    Eide, GE
    Thoresen, SO
    Foulkes, WD
    Akslen, LA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1108 - 1112
  • [5] Survival rates from interval cancer in NHS breast screening programme
    Collins, S
    Woodman, CBJ
    Threlfall, A
    Prior, P
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7134) : 832 - 833
  • [6] A study of interval breast cancer within the NHS breast screening programme
    Cowan, WK
    Angus, B
    Gray, JC
    Lunt, LG
    Al-Tamimi, SR
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (02) : 140 - 146
  • [7] DEGROOTE R, 1983, SURGERY, V94, P543
  • [8] Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain
    Domingo, Laia
    Sala, Maria
    Servitja, Sonia
    Maria Corominas, Josep
    Ferrer, Francisco
    Martinez, Juan
    Macia, Francesc
    Jesus Quintana, Maria
    Albanell, Joan
    Castells, Xavier
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (08) : 1155 - 1164
  • [9] Edge S.B., 2010, AJCC cancer staging manual, V649
  • [10] ERZAAS A, 2003, QUALITY ASSURANCE MA